VERUCCHI, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 399
EU - Europa 340
AS - Asia 101
Continente sconosciuto - Info sul continente non disponibili 1
Totale 841
Nazione #
US - Stati Uniti d'America 396
IT - Italia 273
CN - Cina 48
SG - Singapore 48
DE - Germania 16
FI - Finlandia 13
SE - Svezia 10
GB - Regno Unito 7
BE - Belgio 5
FR - Francia 4
CA - Canada 3
CZ - Repubblica Ceca 3
ID - Indonesia 2
NL - Olanda 2
RU - Federazione Russa 2
TR - Turchia 2
UA - Ucraina 2
AT - Austria 1
EU - Europa 1
IM - Isola di Man 1
IN - India 1
LT - Lituania 1
Totale 841
Città #
Fairfield 52
Santa Clara 46
Chandler 44
Singapore 43
Ashburn 40
Beijing 31
Houston 22
Woodbridge 19
Seattle 17
Cambridge 14
Wilmington 14
Helsinki 13
Milan 13
Bremen 11
Ferrara 11
Princeton 11
San Diego 7
Shanghai 7
Ann Arbor 6
Brussels 4
London 4
Boardman 3
Chilly-mazarin 3
Falkenstein 3
Augusta 2
Falls Church 2
Jacksonville 2
Jakarta 2
Los Angeles 2
Olomouc 2
Rome 2
Toronto 2
Addison 1
Amsterdam 1
Bangalore 1
Dalian 1
Douglas 1
Forlì 1
Frankfurt am Main 1
Fuzhou 1
Grosseto 1
Handan 1
Hounslow 1
Izmir 1
Jinan 1
Nanjing 1
New Bedfont 1
Norwalk 1
Orange 1
Ottawa 1
Parma 1
Pisa 1
Pordenone 1
Prague 1
Rimini 1
San Mateo 1
Shenzhen 1
Stockholm 1
Taiyuan 1
Tianjin 1
Verona 1
Vienna 1
Wandsworth 1
Washington 1
Totale 486
Nome #
Daclatasvir + Sofosbuvir +/- Ribavirin in HIV/HCV co-infected patients with advanced liver disease: preliminary data from the Italian Compassionate Use Program 266
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period 81
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 75
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 70
L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV 61
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 59
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 56
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 55
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 54
Virological response to treatment in patient who start raltegravir in combination with newer agents in current clinical practice 45
Three-years follow up of raltegravir and/or maraviroc-based regimens in patients experienced to PI, NRTI, NNRTI. Update from the ISS-NIA cohort 36
Totale 858
Categoria #
all - tutte 5.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 468
Totale 6.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020155 0 0 0 0 0 2 2 2 34 28 21 66
2020/2021270 99 92 9 9 8 12 3 13 2 10 7 6
2021/202285 5 6 0 1 7 6 4 1 3 11 2 39
2022/2023106 12 12 7 8 21 9 11 8 7 0 11 0
2023/202474 2 10 3 5 10 11 0 5 2 0 3 23
2024/2025138 4 4 25 19 41 45 0 0 0 0 0 0
Totale 858